Role of C-C chemokine receptor type 5 in pathogenesis of malaria and its severe forms.
CCR5
Plasmodium
chemokine system
infection
inflammation
malaria
Journal
International journal of immunogenetics
ISSN: 1744-313X
Titre abrégé: Int J Immunogenet
Pays: England
ID NLM: 101232337
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
revised:
19
06
2024
received:
03
04
2024
accepted:
09
10
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
aheadofprint
Résumé
Malaria is a mosquito-borne disease caused by Plasmodium parasites, responsible for a significant impact on public health in several tropical and sub-tropical countries. The majority of infection cases are classified as uncomplicated malaria, causing mild symptoms such as fever and headache. However, the disease may progress to severe malaria and death if the infection is not properly treated. Furthermore, malaria poses a major concern for children, pregnant women and immunosuppressed individuals. Exacerbated inflammation is characteristic of severe malaria cases. The C-C chemokine receptor type 5 (CCR5) is an important molecule for leukocyte migration and regulation of inflammation. Although widely known as an HIV-1 co-receptor, CCR5 also affects the susceptibility and progression of autoimmune and inflammatory diseases. There is evidence supporting the participation of CCR5 in malaria manifestations, with the evaluation of CCR5 gene expression levels suggested as a marker to monitor malaria severity. Certain genetic variants in the CCR5 gene affect CCR5 expression, potentially altering CCR5-mediated inflammatory responses during malaria infection. However, the complex influences of CCR5 on malaria remain underexplored. Therefore, this review examines and updates the role of CCR5 in various contexts of malaria infection, including uncomplicated malaria, Plasmodium/HIV co-infection, pregnancy and severe (cerebral) malaria.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CAPES
ID : 686/2020
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Aldinucci, D., & Casagrande, N. (2018). Inhibition of the CCL5/CCR5 axis against the progression of gastric cancer. International Journal of Molecular Sciences, 19(5), 1477. https://doi.org/10.3390/ijms19051477
Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007). A dominant function for interleukin 27 in generating interleukin 10‐producing anti‐inflammatory T cells. Nature Immunology, 8(12), 1380–1389. https://doi.org/10.1038/ni1541
Belnoue, E., Costa, F. T., Vigário, A. M., Voza, T., Gonnet, F., Landau, I., Van Rooijen, N., Mack, M., Kuziel, W. A., & Rénia, L. (2003). Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infection and Immunity, 71(6), 3648–3651. https://doi.org/10.1128/IAI.71.6.3648‐3651.2003
Belnoue, E., Kayibanda, M., Deschemin, J. C., Viguier, M., Mack, M., Kuziel, W. A., & Rénia, L. (2003a). CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood, 101(11), 4253–4259. https://doi.org/10.1182/blood‐2002‐05‐1493
Belnoue, E., Potter, S. M., Rosa, D. S., Mauduit, M., Grüner, A. C., Kayibanda, M., Mitchell, A. J., Hunt, N. H., & Rénia, L. (2008). Control of pathogenic CD8+ T cell migration to the brain by IFN‐gamma during experimental cerebral malaria. Parasite Immunology, 30(10), 544–553. https://doi.org/10.1111/j.1365‐3024.2008.01053.x
Bernin, H., & Lotter, H. (2014). Sex bias in the outcome of human tropical infectious diseases: Influence of steroid hormones. The Journal of Infectious Diseases, 209(Suppl 3), S107–S113. https://doi.org/10.1093/infdis/jit610
Bruneel, F. (2019). Human cerebral malaria: 2019 Mini review. Revue Neurologique, 175(7–8), 445–450. https://doi.org/10.1016/j.neurol.2019.07.008
Bujarbaruah, D., Kalita, M. P., Baruah, V., Basumatary, T. K., Hazarika, S., Begum, R. H., Medhi, S., & Bose, S. (2017). RANTES levels as a determinant of falciparum malaria severity or recovery. Parasite Immunology, 39(9), e12452. https://doi.org/10.1111/pim.12452
Cariaco, Y., Durán‐Rodriguez, A. T., Almeida, M. P. O., & Silva, N. M. (2023). CCR5 contributes to adverse outcomes during malaria in pregnancy. Cytokine, 162, 156110. https://doi.org/10.1016/j.cyto.2022.156110
Cariaco, Y., Lima, W. R., Sousa, R., Nascimento, L. A. C., Briceño, M. P., Fotoran, W. L., Wunderlich, G., dos Santos, J. L., & Silva, N. M. (2018). Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL/6 mice. Scientific Reports, 8(1), 1547. https://doi.org/10.1038/s41598‐018‐19840‐x
CDC—Centers for Disease Control and Prevention. (2020). Malaria, biology. Centers for Disease Control and Prevention. https://www.cdc.gov/malaria/about/biology/index.html#tabs‐1‐6
CDC—Centers for Disease Control and Prevention. (2022). Malaria, disease. Centers for Disease Control and Prevention. https://www.cdc.gov/malaria/about/disease.html
Cernetich, A., Garver, L. S., Jedlicka, A. E., Klein, P. W., Kumar, N., Scott, A. L., & Klein, S. L. (2006). Involvement of gonadal steroids and gamma interferon in sex differences in response to blood‐stage malaria infection. Infection and Immunity, 74(6), 3190–3203. https://doi.org/10.1128/IAI.00008‐06
Chan, P. C., Hung, L. M., Huang, J. P., Day, Y. J., Yu, C. L., Kuo, F. C., Lu, C. H., Tian, Y. F., & Hsieh, P. S. (2022). Augmented CCL5/CCR5 signaling in brown adipose tissue inhibits adaptive thermogenesis and worsens insulin resistance in obesity. Clinical Science (London, England: 1979), 136(1), 121–137. https://doi.org/10.1042/CS20210959
Chege, D., Higgins, S. J., McDonald, C. R., Shahabi, K., Huibner, S., Kain, T., Kain, D., Kim, C. J., Leung, N., Amin, M., Geddes, K., Serghides, L., Philpott, D. J., Kimani, J., Gray‐Owen, S., Kain, K. C., & Kaul, R. (2014). Murine Plasmodium chabaudi malaria increases mucosal immune activation and the expression of putative HIV susceptibility markers in the gut and genital mucosae. Journal of Acquired Immune Deficiency Syndromes, 65(5), 517–525. https://doi.org/10.1097/QAI.0000000000000056
Clark, C. J., & Phillips, R. S. (2011). Cerebral malaria protection in mice by species‐specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain. Parasite Immunology, 33(11), 637–641. https://doi.org/10.1111/j.1365‐3024.2011.01329.x
Coban, C., Ishii, K. J., Uematsu, S., Arisue, N., Sato, S., Yamamoto, M., Kawai, T., Takeuchi, O., Hisaeda, H., Horii, T., & Akira, S. (2007). Pathological role of toll‐like receptor signaling in cerebral malaria. International Immunology, 19(1), 67–79. https://doi.org/10.1093/intimm/dxl123
Cuesta‐Llavona, E., Gómez, J., Albaiceta, G. M., Amado‐Rodríguez, L., García‐Clemente, M., Gutiérrez‐Rodríguez, J., López‐Alonso, I., Hermida, T., Enríquez, A. I., Hernández‐González, C., Gil‐Peña, H., Domínguez‐Garrido, E., Pérez‐Oliveira, S., Alvarez, V., López‐Larrea, C., Suarez‐Alvarez, B., Tranche, S., Jimeno‐Demuth, F. J., & Coto, E. (2021). Variant‐genetic and transcript‐expression analysis showed a role for the chemokine‐receptor CCR5 in COVID‐19 severity. International Immunopharmacology, 98, 107825. https://doi.org/10.1016/j.intimp.2021.107825
de Carvalho, R. V. H., & Zamboni, D. S. (2020). Inflammasome activation in response to intracellular protozoan parasites. Trends in Parasitology, 36(5), 459–472. https://doi.org/10.1016/j.pt.2020.02.006
Diou, J., Tardif, M. R., Barat, C., & Tremblay, M. J. (2010). Malaria hemozoin modulates susceptibility of immature monocyte‐derived dendritic cells to HIV‐1 infection by inducing a mature‐like phenotype. Cellular Microbiology, 12(5), 615–625. https://doi.org/10.1111/j.1462‐5822.2009.01420.x
Dunst, J., Kamena, F., & Matuschewski, K. (2017). Cytokines and chemokines in cerebral malaria pathogenesis. Frontiers in Cellular and Infection Microbiology, 7, 324. https://doi.org/10.3389/fcimb.2017.00324
Edwards, C. L., Ng, S. S., de Labastida Rivera, F., Corvino, D., Engel, J. A., Montes de Oca, M., Bukali, L., Frame, T. C., Bunn, P. T., Chauhan, S. B., Singh, S. S., Wang, Y., Na, J., Amante, F. H., Loughland, J. R., Soon, M. S., Waddell, N., Mukhopadhay, P., Koufariotis, L. T., … Engwerda, C. R. (2023). IL‐10‐producing Th1 cells possess a distinct molecular signature in malaria. The Journal of Clinical Investigation, 133(1), e153733. https://doi.org/10.1172/JCI153733
Ellwanger, J. H., & Chies, J. A. B. (2019). Host immunogenetics in tick‐borne encephalitis virus infection‐The CCR5 crossroad. Ticks and Tick‐Borne Diseases, 10(4), 729–741. https://doi.org/10.1016/j.ttbdis.2019.03.005
Ellwanger, J. H., Kaminski, V. L., & Chies, J. A. (2020). What we say and what we mean when we say redundancy and robustness of the chemokine system—how CCR5 challenges these concepts. Immunology and Cell Biology, 98(1), 22–27. https://doi.org/10.1111/imcb.12291
Ellwanger, J. H., Kaminski, V. L., Rodrigues, A. G., Kulmann‐Leal, B., & Chies, J. A. B. (2020). CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box. International Journal of Immunogenetics, 47(3), 261–285. https://doi.org/10.1111/iji.12485
Ellwanger, J. H., Kulmann‐Leal, B., Kaminski, V. L., Rodrigues, A. G., Bragatte, M. A. S., & Chies, J. A. B. (2020). Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases. Virus Research, 286, 198040. https://doi.org/10.1016/j.virusres.2020.198040
Fattakhov, N., Ngo, A., Torices, S., Joseph, J. A., Okoro, A., Moore, C., Naranjo, O., Becker, S., & Toborek, M. (2024). Cenicriviroc prevents dysregulation of astrocyte/endothelial cross talk induced by ischemia and HIV‐1 via inhibiting the NLRP3 inflammasome and pyroptosis. American Journal of Physiology; Cell Physiology, 326(2), C487–C504. https://doi.org/10.1152/ajpcell.00600.2023
Feeney, M. E. (2020). The immune response to malaria in utero. Immunological Reviews, 293(1), 216–229. https://doi.org/10.1111/imr.12806
Ferreira, M. U., & Castro, M. C. (2016). Challenges for malaria elimination in Brazil. Malaria Journal, 15(1), 284. https://doi.org/10.1186/s12936‐016‐1335‐1
Festa, B. P., Siddiqi, F. H., Jimenez‐Sanchez, M., Won, H., Rob, M., Djajadikerta, A., Stamatakou, E., & Rubinsztein, D. C. (2023). Microglial‐to‐neuronal CCR5 signaling regulates autophagy in neurodegeneration. Neuron, 111(13), 2021–2037.e12. https://doi.org/10.1016/j.neuron.2023.04.06
Findlay, E. G., Villegas‐Mendez, A., de Souza, J. B., Inkson, C. A., Shaw, T. N., Saris, C. J., Hunter, C. A., Riley, E. M., & Couper, K. N. (2013). IL‐27 receptor signaling regulates CD4+ T cell chemotactic responses during infection. Journal of Immunology (Baltimore, Md.: 1950), 190(9), 4553–4561. https://doi.org/10.4049/jimmunol.1202916
Hansen, D. S., Bernard, N. J., Nie, C. Q., & Schofield, L. (2007). NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei‐mediated cerebral malaria. Journal of Immunology (Baltimore, Md.: 1950), 178(9), 5779–5788. https://doi.org/10.4049/jimmunol.178.9.5779
Hazan, U., Romero, I. A., Cancello, R., Valente, S., Perrin, V., Mariot, V., Dumonceaux, J., Gerhardt, C. C., Strosberg, A. D., Couraud, P. O., & Pietri‐Rouxel, F. (2002). Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: A new target cell type for the immunodeficiency virus‐1?. FASEB Journal, 16(10), 1254–1256. https://doi.org/10.1096/fj.01‐0947fje
Hirako, I. C., Assis, P. A., Galvão‐Filho, B., Luster, A. D., Antonelli, L. R., & Gazzinelli, R. T. (2019). Monocyte‐derived dendritic cells in malaria. Current Opinion in Microbiology, 52, 139–150. https://doi.org/10.1016/j.mib.2019.08.002
Hirako, I. C., Ataide, M. A., Faustino, L., Assis, P. A., Sorensen, E. W., Ueta, H., Araújo, N. M., Menezes, G. B., Luster, A. D., & Gazzinelli, R. T. (2016). Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte‐derived dendritic cells in the brain during cerebral malaria. Nature Communications, 7, 13277. https://doi.org/10.1038/ncomms13277
Hochman, S., & Kim, K. (2012). The impact of HIV coinfection on cerebral malaria pathogenesis. Journal of Neuroparasitology, 3, 235547. https://doi.org/10.4303/jnp/235547
Horioka, M., Ceraudo, E., Lorenzen, E., Sakmar, T. P., & Huber, T. (2021). Purinergic receptors crosstalk with CCR5 to amplify Ca2+ signaling. Cellular and Molecular Neurobiology, 41(5), 1085–1101. https://doi.org/10.1007/s10571‐020‐01002‐1
Jaramillo, M., Plante, I., Ouellet, N., Vandal, K., Tessier, P. A., & Olivier, M. (2004). Hemozoin‐inducible proinflammatory events in vivo: Potential role in malaria infection. Journal of Immunology (Baltimore, Md.: 1950), 172(5), 3101–3110. https://doi.org/10.4049/jimmunol.172.5.3101
Jaworowski, A., Kamwendo, D. D., Ellery, P., Sonza, S., Mwapasa, V., Tadesse, E., Molyneux, M. E., Rogerson, S. J., Meshnick, S. R., & Crowe, S. M. (2007). CD16+ monocyte subset preferentially harbors HIV‐1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV‐1 infection. The Journal of Infectious Diseases, 196(1), 38–42. https://doi.org/10.1086/518443
Jenkins, N. E., Chakravorty, S. J., Urban, B. C., Kai, O. K., Marsh, K., & Craig, A. G. (2006). The effect of Plasmodium falciparum infection on expression of monocyte surface molecules. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100(11), 1007–1012. https://doi.org/10.1016/j.trstmh.2006.01.005
Joubert, B. R., Franceschini, N., Mwapasa, V., North, K. E., & Meshnick, S. R. (2010). Regulation of CCR5 expression in human placenta: Insights from a study of mother‐to‐child transmission of HIV in Malawi. PLoS ONE, 5(2), e9212. https://doi.org/10.1371/journal.pone.0009212
Kaminski, V. L., Ellwanger, J. H., Sandrim, V., Pontillo, A., & Chies, J. A. B. (2019). Influence of NKG2C gene deletion and CCR5Δ32 in pre‐eclampsia‐approaching the effect of innate immune gene variants in pregnancy. International Journal of Immunogenetics, 46(2), 82–87. https://doi.org/10.1111/iji.12416
Khan, I. A., Thomas, S. Y., Moretto, M. M., Lee, F. S., Islam, S. A., Combe, C., Schwartzman, J. D., & Luster, A. D. (2006). CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathogens, 2(6), e49. https://doi.org/10.1371/journal.ppat.0020049
Kitade, H., Sawamoto, K., Nagashimada, M., Inoue, H., Yamamoto, Y., Sai, Y., Takamura, T., Yamamoto, H., Miyamoto, K., Ginsberg, H. N., Mukaida, N., Kaneko, S., & Ota, T. (2012). CCR5 plays a critical role in obesity‐induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes, 61(7), 1680–1690. https://doi.org/10.2337/db11‐1506
Kulmann‐Leal, B., Ellwanger, J. H., & Chies, J. A. B. (2020). A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer. Hematology, Transfusion and Cell Therapy, 42(1), 70–76. https://doi.org/10.1016/j.htct.2019.10.001
Kulmann‐Leal, B., Ellwanger, J. H., & Chies, J. A. B. (2021). CCR5Δ32 in Brazil: Impacts of a European genetic variant on a highly admixed population. Frontiers in Immunology, 12, 758358. https://doi.org/10.3389/fimmu.2021.758358
Kumar, R., Loughland, J. R., Ng, S. S., Boyle, M. J., & Engwerda, C. R. (2020). The regulation of CD4+ T cells during malaria. Immunological Reviews, 293(1), 70–87. https://doi.org/10.1111/imr.12804
Lin, J., Xu, Y., Guo, P., Chen, Y. J., Zhou, J., Xia, M., Tan, B., Liu, X., Feng, H., & Chen, Y. (2023). CCL5/CCR5‐mediated peripheral inflammation exacerbates blood‒brain barrier disruption after intracerebral hemorrhage in mice. Journal of Translational Medicine, 21(1), 196. https://doi.org/10.1186/s12967‐023‐04044‐3
Liu, G., Qin, L., Li, Y., Zhao, S., Shugay, M., Yan, Y., Ye, Y., Chen, Y., Huang, C., Bayaer, N., Adah, D., Zhang, H., Su, Z., & Chen, X. (2022). Subsequent malaria enhances virus‐specific T cell immunity in SIV‐infected Chinese rhesus macaques. Cell Communication and Signaling, 20(1), 101. https://doi.org/10.1186/s12964‐022‐00910‐7
Mahittikorn, A., Kotepui, K. U., De Jesus Milanez, G., Masangkay, F. R., & Kotepui, M. (2021). A meta‐analysis on the prevalence and characteristics of severe malaria in patients with Plasmodium spp. and HIV co‐infection. Scientific Reports, 11(1), 16655. https://doi.org/10.1038/s41598‐021‐95591‐6
Mehlotra, R. K. (2019). CCR5 promoter polymorphism ‐2459G >A: Forgotten or ignored?. Cells, 8(7), 651. https://doi.org/10.3390/cells8070651
Miller, L. H., Baruch, D. I., Marsh, K., & Doumbo, O. K. (2002). The pathogenic basis of malaria. Nature, 415(6872), 673–679. https://doi.org/10.1038/415673a
Moriuchi, M., Moriuchi, H., Mon, H. M., & Kanbara, H. (2002). Dichotomous effects of Plasmodium falciparum antigens on expression of human immunodeficiency virus (HIV) coreceptors and on infectability of CD4 cells by HIV. The Journal of Infectious Diseases, 186(8), 1194–1197. https://doi.org/10.1086/343814
Nishanth, G., & Schlüter, D. (2019). Blood‐brain barrier in cerebral malaria: Pathogenesis and therapeutic intervention. Trends in Parasitology, 35(7), 516–528. https://doi.org/10.1016/j.pt.2019.04.010
Nishimura, M., Umeda, K., Suwa, M., Furuoka, H., & Nishikawa, Y. (2017). CCR5 is involved in interruption of pregnancy in mice infected with Toxoplasma gondii during early pregnancy. Infection and Immunity, 85(9), e00257–17. https://doi.org/10.1128/IAI.00257‐17
Nitcheu, J., Bonduelle, O., Combadiere, C., Tefit, M., Seilhean, D., Mazier, D., & Combadiere, B. (2003). Perforin‐dependent brain‐infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. Journal of Immunology (Baltimore, Md.: 1950), 170(4), 2221–2228. https://doi.org/10.4049/jimmunol.170.4.2221
Nyariki, J. N., Kimani, N. M., Kibet, P. S., Kinuthia, G. K., & Isaac, A. O. (2023). Coenzyme Q10 exhibits anti‐inflammatory and immune‐modulatory thereby decelerating the occurrence of experimental cerebral malaria. Molecular and Biochemical Parasitology, 255, 111579. https://doi.org/10.1016/j.molbiopara.2023.111579
Parveen, F., Tripathi, G., Singh, B., & Agrawal, S. (2009). Association of chemokines receptor (CCR5 Delta32) in idiopathic recurrent miscarriages among north Indians. Archives of Gynecology and Obstetrics, 280(2), 229–234. https://doi.org/10.1007/s00404‐008‐0901‐3
Pathak, S., Rege, M., Gogtay, N. J., Aigal, U., Sharma, S. K., Valecha, N., Bhanot, G., Kshirsagar, N. A., & Sharma, S. (2012). Age‐dependent sex bias in clinical malarial disease in hypoendemic regions. PLoS ONE, 7(4), e35592. https://doi.org/10.1371/journal.pone.0035592
Poh, C. M., Howland, S. W., Grotenbreg, G. M., & Rénia, L. (2014). Damage to the blood‐brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities. Infection and Immunity, 82(11), 4854–4864. https://doi.org/10.1128/IAI.02180‐14
Pollenus, E., Gouwy, M., & Van den Steen, P. E. (2022). Neutrophils in malaria: The good, the bad or the ugly? Parasite Immunology, 44(6), e12912. https://doi.org/10.1111/pim.12912
Reis, A. S., Barboza, R., Murillo, O., Barateiro, A., Peixoto, E. P. M., Lima, F. A., Gomes, V. M., Dombrowski, J. G., Leal, V. N. C., Araujo, F., Bandeira, C. L., Araujo, R. B. D., Neres, R., Souza, R. M., Costa, F. T. M., Pontillo, A., Bevilacqua, E., Wrenger, C., Wunderlich, G., … Marinho, C. R. F. (2020). Inflammasome activation and IL‐1 signaling during placental malaria induce poor pregnancy outcomes. Science Advances, 6(10), eaax6346. https://doi.org/10.1126/sciadv.aax6346
Reis, S. M., Bugs, C. A., Chies, J. A. B., & Canedo, A. D. (2023). Uncovering disease‐related polymorphisms through correlations between SNP frequencies, population and epidemiological data. BioMedInformatics, 3(2), 467–477. https://doi.org/10.3390/biomedinformatics3020032
Sachs, J., & Malaney, P. (2002). The economic and social burden of malaria. Nature, 415(6872), 680–685. https://doi.org/10.1038/415680a
Saito, M., Briand, V., Min, A. M., & McGready, R. (2020). Deleterious effects of malaria in pregnancy on the developing fetus: A review on prevention and treatment with antimalarial drugs. The Lancet. Child & Adolescent Health, 4(10), 761–774. https://doi.org/10.1016/S2352‐4642(20)30099‐7
Sallusto, F., & Baggiolini, M. (2008). Chemokines and leukocyte traffic. Nature Immunology, 9(9), 949–952. https://doi.org/10.1038/ni.f.214
Sánchez, K. E., & Spencer, L. M. (2022). Pregnancy‐associated malaria: Effects of cytokine and chemokine expression. Travel Medicine and Infectious Disease, 47, 102282. https://doi.org/10.1016/j.tmaid.2022.102282
Santos, M. L. S., Reis, E. C., Bricher, P. N., Sousa, T. N., Brito, C. F. A., Lacerda, M. V. G., Fontes, C. J. F., Carvalho, L. H., & Pontillo, A. (2016). Contribution of inflammasome genetics in Plasmodium vivax malaria. Infection Genetics and Evolution, 40, 162–166. https://doi.org/10.1016/j.meegid.2016.02.038
Sarfo, B. Y., Armah, H. B., Irune, I., Adjei, A. A., Olver, C. S., Singh, S., Lillard, J. W. Jr., & Stiles, J. K. (2005). Plasmodium yoelii 17XL infection up‐regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum. Malaria Journal, 4, 63. https://doi.org/10.1186/1475‐2875‐4‐63
Sarfo, B. Y., Singh, S., Lillard, J. W., Quarshie, A. Jr., Gyasi, R. K., Armah, H., Adjei, A. A., Jolly, P., & Stiles, J. K. (2004). The cerebral‐malaria‐associated expression of RANTES, CCR3 and CCR5 in post‐mortem tissue samples. Annals of Tropical Medicine and Parasitology, 98(3), 297–303. https://doi.org/10.1179/000349804225003271
Scheunemann, J. F., Reichwald, J. J., Korir, P. J., Kuehlwein, J. M., Jenster, L. M., Hammerschmidt‐Kamper, C., Lewis, M. D., Klocke, K., Borsche, M., Schwendt, K. E., Soun, C., Thiebes, S., Limmer, A., Engel, D. R., Mueller, A. K., Hoerauf, A., Hübner, M. P., & Schumak, B. (2021). Eosinophils suppress the migration of T cells into the brain of Plasmodium berghei‐infected Ifnar1−/− mice and protect them from experimental cerebral malaria. Frontiers in Immunology, 12, 711876. https://doi.org/10.3389/fimmu.2021.711876
Schofield, L., & Grau, G. E. (2005). Immunological processes in malaria pathogenesis. Nature Reviews. Immunology, 5(9), 722–735. https://doi.org/10.1038/nri1686
Shen, Y., Zhou, M., Cai, D., Filho, D. A., Fernandes, G., Cai, Y., de Sousa, A. F., Tian, M., Kim, N., Lee, J., Necula, D., Zhou, C., Li, S., Salinas, S., Liu, A., Kang, X., Kamata, M., Lavi, A., Huang, S., … Silva, A. J. (2022). CCR5 closes the temporal window for memory linking. Nature, 606(7912), 146–152. https://doi.org/10.1038/s41586‐022‐04783‐1
Silva‐Filho, J. L., Caruso‐Neves, C., & Pinheiro, A. A. (2016). Angiotensin II type‐1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen‐specific CD8+ T cells. Scientific Reports, 6, 35997. https://doi.org/10.1038/srep35997
Silva‐Filho, J. L., Caruso‐Neves, C., & Pinheiro, A. A. (2017). Targeting angiotensin II type‐1 receptor (AT1R) inhibits the harmful phenotype of Plasmodium‐specific CD8+ T cells during blood‐stage malaria. Frontiers in Cellular and Infection Microbiology, 7, 42. https://doi.org/10.3389/fcimb.2017.00042
Silva‐Filho, J. L., Souza, M. C., Ferreira‐Dasilva, C. T., Silva, L. S., Costa, M. F., Padua, T. A., Henriques, M. D., Morrot, A., Savino, W., Caruso‐Neves, C., & Pinheiro, A. A. (2013). Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection. PLoS ONE, 8(4), e62999. https://doi.org/10.1371/journal.pone.0062999
Singh, S., Bruder‐Nascimento, A., Belin de Chantemele, E. J., & Bruder‐Nascimento, T. (2022). CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1. Biochemical Pharmacology, 195, 114859. https://doi.org/10.1016/j.bcp.2021.114859
Solloch, U. V., Lang, K., Lange, V., Böhme, I., Schmidt, A. H., & Sauter, J. (2017). Frequencies of gene variant CCR5‐Δ32 in 87 countries based on next‐generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers. Human Immunology, 78(11–12), 710–717. https://doi.org/10.1016/j.humimm.2017.10.001
Terahara, K., Iwabuchi, R., Iwaki, R., Takahashi, Y., & Tsunetsugu‐Yokota, Y. (2021). Substantial induction of non‐apoptotic CD4 T‐cell death during the early phase of HIV‐1 infection in a humanized mouse model. Microbes and Infection, 23(1), 104767. https://doi.org/10.1016/j.micinf.2020.10.003
Tkachuk, A. N., Moormann, A. M., Poore, J. A., Rochford, R. A., Chensue, S. W., Mwapasa, V., & Meshnick, S. R. (2001). Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. The Journal of Infectious Diseases, 183(6), 967–972. https://doi.org/10.1086/319248
Villarino, A. V., Stumhofer, J. S., Saris, C. J., Kastelein, R. A., de Sauvage, F. J., & Hunter, C. A. (2006). IL‐27 limits IL‐2 production during Th1 differentiation. Journal of Immunology (Baltimore, Md.: 1950), 176(1), 237–247. https://doi.org/10.4049/jimmunol.176.1.237
WHO—World Health Organization. (2023a). Malaria. World Health Organization. https://www.who.int/news‐room/fact‐sheets/detail/malaria
WHO—World Health Organization. (2023b). World malaria report 2023. World Health Organization.
Xiao, L., Owen, S. M., Rudolph, D. L., Lal, R. B., & Lal, A. A. (1998). Plasmodium falciparum antigen‐induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor‐α. The Journal of Infectious Diseases, 177(2), 437–445. https://doi.org/10.1086/514212
Yan, J., Xu, W., Lenahan, C., Huang, L., Wen, J., Li, G., Hu, X., Zheng, W., Zhang, J. H., & Tang, J. (2021). CCR5 activation promotes NLRP1‐dependent neuronal pyroptosis via CCR5/PKA/CREB pathway after intracerebral hemorrhage. Stroke, 52(12), 4021–4032. https://doi.org/10.1161/STROKEAHA.120.033285
Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2022). CCL5/CCR5 axis in human diseases and related treatments. Genes & Diseases, 9(1), 12–27. https://doi.org/10.1016/j.gendis.2021.08.004
Zhao, X., Yin, F., Fu, L., Ma, Y., Ye, L., Huang, Y., Fan, W., Gao, W., Cai, Y., & Mou, X. (2023). Garlic‐derived exosome‐like nanovesicles as a hepatoprotective agent alleviating acute liver failure by inhibiting CCR2/CCR5 signaling and inflammation. Biomaterials Advances, 154, 213592. https://doi.org/10.1016/j.bioadv.2023.213592